News
EyePoint
New AMD drug completes Phase 2 trial
EyePoint Pharmaceuticals announced the completion of the Phase 2 trial of their new experimental drug, vorolanib, for the treatment of wet age-related macular degeneration.
intravitreal injection
New eye drops may be potential new treatment for wet AMD
The current available therapies available to treat wet AMD involve intravitreal injections delivered every month to the back of the eye.
AMD
One neovascular AMD treatment more effective than the other
A recent study reveals that one anti-VEGF treatment is more effective than another commonly used treatment.
age-related macular degeneration
Oranges lower risk of severe vision loss by 60%
Researchers believe the flavonoids in oranges offer protection against late stage macular degeneration.
age-related macular degeneration
Study indicates some patients may be "weaned" off injections for wet macular degeneration
Study results offer hope to patients with wet macular degeneration who are receiving anti-VEGF injections.
areds 2
Strategies Eye Doctors use for their Patients with Dry Macular Degeneration
I don't want to see ANY progression on their photographs or optical scans. If I do, I modify strategies.
lucentis
No more monthly injections for wet macular degeneration?
The FDA just approved ranibizumab (Lucentis) as an ocular implant to be injected into the eye for people with wet macular degeneration, based upon the successful Archway study run under the FDA umb...
age-related macular degeneration
Damaging DNA buildup in eyes of those with macular degeneration can lead to blindness
A recent study was published in the journal Science Advances which sheds light on how a build-up of damaging DNA in the eyes of people with macular degeneration can lead to blindness.
age-related macular degeneration
New Anti-VEGF treatment has positive results in first clinical trial
EyePoint Pharmaceuticals recently announced results of the Phase 1 clinical trial of their new wet age-related macular degeneration treatment, EYP-1901.